Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.13M Sell
9,403
-187
-2% -$21.6K 0.27% 84
2025
Q4
$1.01M Buy
9,590
+885
+10% +$83.1K 0.26% 86
2025
Q3
$731K Sell
8,705
-1,418
-14% -$117K 0.2% 103
2025
Q2
$801K Buy
10,123
+2,868
+40% +$228K 0.26% 90
2025
Q1
$651K Buy
7,255
+4,472
+161% +$418K 0.23% 81
2024
Q4
$277K Buy
2,783
+207
+8% +$21.3K 0.15% 94
2024
Q3
$293K Buy
+2,576
New +$306K 0.15% 90

Other funds holding MRK

Plan Group Financial's MRK Position: Q1 2026 in Review

Plan Group Financial reduced its Merck (MRK) stake by 1.9% in Q1 2026, selling an estimated $21.6K and leaving 9,403 shares worth $1.13M. The position accounts for 0.27% of the portfolio, ranked #84.

Plan Group Financial first reported a position in MRK in Q3 2024 and has held it in 7 quarters since. 3,778 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Plan Group Financial held 9,403 shares of Merck worth $1.13M as of Q1 2026.
  • Plan Group Financial sold 187 Merck shares in Q1 2026, an estimated $21.6K.
  • Merck made up 0.27% of Plan Group Financial's portfolio in Q1 2026, its #84 holding.
  • Plan Group Financial first reported a position in Merck in Q3 2024 and has held it in 7 quarters since.
  • 3,778 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Plan Group Financial's 13F filing for Q1 2026, filed 13 Apr 2026.